A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
Phase of Trial: Phase IV
Latest Information Update: 10 Dec 2014
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors MedImmune
- 21 Jan 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 24 Jun 2013 Actual initation date (Jun 2013) added as reported by ClinicalTrials.gov.
- 24 Jun 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.